These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27444352)

  • 1. A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care.
    Karachaliou F; Athanasakis K; Tsentidis C; Soldatou A; Simatos G; Kyriopoulos J; Michalakos S; Karavanaki K
    Pediatr Diabetes; 2017 Aug; 18(5):405-412. PubMed ID: 27444352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of insurance coverage and the family on pediatric diabetes management.
    Watson SE; Kuhl EA; Foster MB; Omoruyi AO; Kingery SE; Woods C; Wintergerst KA
    Pediatr Diabetes; 2017 Jun; 18(4):315-319. PubMed ID: 27161659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: an Italian multicentre survey.
    Gesuita R; Skrami E; Bonfanti R; Cipriano P; Ferrito L; Frongia P; Iafusco D; Iannilli A; Lombardo F; Mozzillo E; Paleari R; Rabbone I; Sabbion A; Salvatoni A; Scaramuzza A; Schiaffini R; Sulli N; Toni S; Carle F; Cherubini V
    Pediatr Diabetes; 2017 May; 18(3):241-248. PubMed ID: 26990605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study.
    Melidonis A; Kamaratos A; Angelidi A; Thomakos P; Vrakas S; Bakalis J; Fousteris E; Iraklianou S
    Diabetes Technol Ther; 2016 Mar; 18(3):159-63. PubMed ID: 26862678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
    Giménez M; Elías I; Álvarez M; Quirós C; Conget I
    Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
    Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
    J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of depressive symptoms in well-controlled adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Zduńczyk B; Sendela J; Szypowska A
    Diabetes Metab Res Rev; 2014 May; 30(4):333-8. PubMed ID: 24323887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.
    Roze S; Smith-Palmer J; Valentine W; de Portu S; Nørgaard K; Pickup JC
    Diabet Med; 2015 Nov; 32(11):1415-24. PubMed ID: 25962621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of deprivation, ethnicity, and insulin pump therapy on developmental trajectories of diabetes control in COB type 1 diabetes.
    Viner RM; White B; Amin R; Peters C; Khanolkar A; Christie D; Hindmarsh PC
    Pediatr Diabetes; 2017 Aug; 18(5):384-391. PubMed ID: 27534520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
    Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
    Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
    Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion.
    Nixon R; Folwell R; Pickup JC
    Diabet Med; 2014 Oct; 31(10):1174-7. PubMed ID: 24804864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey.
    Roze S; Smith-Palmer J; de Portu S; Özdemir Saltik AZ; Akgül T; Deyneli O
    Diabetes Technol Ther; 2019 Dec; 21(12):727-735. PubMed ID: 31509715
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy.
    Wen W; Frampton R; Wright K; Fattore S; Shadbolt B; Perampalam S
    Diabet Med; 2016 Feb; 33(2):231-4. PubMed ID: 26484625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin regimens, diabetes knowledge, quality of life, and HbA1c in children and adolescents with type 1 diabetes.
    Keller M; Attia R; Beltrand J; Djadi-Prat J; Nguyen-Khoa T; Jay JP; Cahané M; Choleau C; Robert JJ
    Pediatr Diabetes; 2017 Aug; 18(5):340-347. PubMed ID: 27161814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
    Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
    Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical activity and sedentary behavior levels in children and adolescents with type 1 diabetes using insulin pump or injection therapy - The importance of parental activity profile.
    Michaud I; Henderson M; Legault L; Mathieu ME
    J Diabetes Complications; 2017 Feb; 31(2):381-386. PubMed ID: 27989545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control.
    Anyanwagu U; Olaoye H; Jennings P; Ashton-Cleary S; Sugunendran S; Hughes D; Idris I; Wilmot EG
    Diabet Med; 2017 Aug; 34(8):1154-1157. PubMed ID: 28430381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.